Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50,200
Closed -$315K 1273
2021
Q4
$315K Sell
50,200
-37,200
-43% -$254K ﹤0.01% 1145
2021
Q3
$695K Sell
87,400
-125,600
-59% -$1.03M ﹤0.01% 1054
2021
Q2
$1.59M Buy
213,000
+123,800
+139% +$864K ﹤0.01% 821
2021
Q1
$540K Buy
89,200
+35,200
+65% +$271K ﹤0.01% 949
2020
Q4
$308K Sell
54,000
-65,400
-55% -$416K ﹤0.01% 997
2020
Q3
$794K Buy
+119,400
New +$1.06M ﹤0.01% 776

Other funds holding VXRT

IMC Chicago's VXRT Position: Q4 2021 in Review

IMC Chicago sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 34,913 shares — an estimated $238K sold.

IMC Chicago first reported a position in VXRT in Q2 2021 and held it in 2 quarters. The position peaked at $278K in Q3 2021. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

  • IMC Chicago reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
  • IMC Chicago sold 34,913 Vaxart shares in Q4 2021, an estimated $238K.
  • IMC Chicago first reported a position in Vaxart in Q2 2021 and held it in 2 quarters.
  • IMC Chicago's Vaxart position peaked at $278K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on IMC Chicago's 13F filing for Q4 2021, filed 8 Feb 2022.